What happened: A “60-plus therapy model” for older cancer patients
A health feature describes rising cancer incidence among people aged 60 and above and frames geriatric oncology as an emerging care need. The feature presents a “60-plus therapy model” aimed at improving outcomes for older patients by tailoring cancer treatment to age-related risks rather than applying standard cancer regimens uniformly.
The model is described around three linked priorities in cancer care for older adults: fitness-for-therapy assessment (whether an older patient can safely tolerate planned treatment), care coordination (aligning different care steps across the therapy pathway), and toxicity management (monitoring and managing treatment side effects to support safer continuity of evidence-based treatment).
Background and earlier position: Standard oncology regimens vs older-age constraints
Standard cancer treatment protocols are commonly built from clinical trial evidence and general treatment pathways. Older cancer patients often have a different risk profile because of comorbidities (multiple medical conditions) and reduced functional status (limitations in daily activities), both of which can increase the risk of harm during therapy if treatment is applied as a single uniform plan.
In this setting, geriatric oncology is positioned as a way to incorporate age-related vulnerability into therapy decisions and supportive care rather than treating older adults as identical to younger patients.